In today’s recent session, 0.71 million shares of the Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) have been traded, and its beta is -0.07. Most recently the company’s share price was $5.63, and it changed around $0.4 or 7.61% from the last close, which brings the market valuation of the company to $1.42B. MRVI at last check was trading at a discount to its 52-week high of $11.56, offering almost -105.33% off that amount. The share price’s 52-week low was $4.28, which indicates that the recent value has risen by an impressive 23.98% since then. We note from Maravai LifeSciences Holdings Inc’s average daily trading volume that its 10-day average is 2.35 million shares, with the 3-month average coming to 2.02 million.
Maravai LifeSciences Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.13. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 6 recommended MRVI as a Hold, whereas 8 deemed it a Buy, and 1 rated it as Underweight.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) trade information
Instantly MRVI has been showing a green trend so far today with a performance of 7.61% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 5.47 on recent trading daydecreased the stock’s daily price by -2.93%. The company’s shares are currently up 3.27% year-to-date, but still up 23.96% over the last five days. On the other hand, Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) is 0.86% up in the 30-day period. We can see from the shorts that 8.51 million shares have been sold at a short interest cover period of 5.65 day(s).
The consensus price target as assigned by Wall Street analysts is $22, which translates to bulls needing to increase their stock price by 74.41% from its current value. Analyst projections state that MRVI is forecast to be at a low of $10 and a high of $25.
Maravai LifeSciences Holdings Inc (MRVI) estimates and forecasts
Maravai LifeSciences Holdings Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -32.52 percent over the past six months and at a -366.67% annual growth rate that is well below the industry average of 11.80%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -37.53%. Maravai LifeSciences Holdings Inc earnings are expected to increase by -365.75% in 2025, but the outlook is positive 16.73% per year for the next five years.
MRVI Dividends
Maravai LifeSciences Holdings Inc’s next quarterly earnings report is expected to be released in February.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.20% of Maravai LifeSciences Holdings Inc shares, and 102.63% of them are in the hands of institutional investors. The stock currently has a share float of 103.88%. Maravai LifeSciences Holdings Inc stock is held by 303.0 institutions, with GTCR LLC being the largest institutional investor. By 2024-06-30, it held 15.2267% of the shares, which is about 20.15 million shares worth $144.27 million.
12 WEST CAPITAL MANAGEMENT LP, with 9.9833% or 13.21 million shares worth $94.59 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 3.94 shares worth $22.49 million, making up 2.78% of all outstanding shares. On the other hand, Vanguard Small-Cap Index Fund held roughly 3.02 shares worth around $17.22 million, which represents about 2.13% of the total shares outstanding.
